Daniel E. Hemli

Daniel E. Hemli

Bracewell & Giuliani LLP

Contact  |  View Bio  |  RSS

Latest Posts › Prescription Drugs

Share:

FTC Broadens Notification Requirements for Transfers of Pharmaceutical Patent Rights

The Federal Trade Commission (FTC) has revised the rule for determining when a transfer of exclusive rights to a patent in the pharmaceutical industry (including biologics and medicine manufacturing) results in a potentially...more

11/13/2013 - DOJ FTC Hart-Scott-Rodino Act Patents Pharmaceutical Prescription Drugs

High Court Finds Antitrust Scrutiny Applies to Pay-for-Delay Settlements

On June 17, 2013, the U.S. Supreme Court determined that the Federal Trade Commission’s (FTC) antitrust challenge to a reverse payment settlement agreement between drug manufacturers, otherwise known as a “pay-for-delay”...more

6/24/2013 - Actavis Inc. FTC FTC v Actavis Generic Drugs Patents Pay-For-Delay Prescription Drugs Reverse Payment Settlement Agreements SCOTUS

2 Results
|
View per page
Page: of 1